USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$39.50 USD
+0.10 (0.25%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $39.46 -0.04 (-0.10%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
USNA 39.50 +0.10(0.25%)
Will USNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USNA
USANA Health Sciences (USNA) Misses Q2 Earnings and Revenue Estimates
USNA vs. ZTS: Which Stock Is the Better Value Option?
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USNA or ZTS: Which Is the Better Value Stock Right Now?
USNA vs. ZTS: Which Stock Is the Better Value Option?
USNA vs. STVN: Which Stock Should Value Investors Buy Now?
Other News for USNA
USANA Executive Chairman Kevin Guest Shares 7 Steps to Soar Like Olympians
Warning: USNA is at high risk of performing badly
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Phreesia (PHR) and USANA Health (USNA)
Usana price target lowered by $8 at DA Davidson, here's why
Usana Health Sciences Inc (USNA) Q2 2024 Earnings Call Transcript Highlights: Strategic ...